TI
MNTA

Telemetry Investments’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Telemetry Investments’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,500
Closed -$971K – 108
2020
Q3 		$971K Buy
+18,500
New +$766K 2.11% 13

Telemetry Investments's MNTA Position: Q4 2020 in Review

Telemetry Investments sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 18,500 shares — an estimated $971K sold.

Telemetry Investments first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $971K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Telemetry Investments reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Telemetry Investments sold 18,500 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $971K.
  • Telemetry Investments first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Telemetry Investments's Momenta Pharmaceuticals, Inc. position peaked at $971K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Telemetry Investments's 13F filing for Q4 2020, filed 16 Feb 2021.